Genuine 12-Qubit Entanglement on a Superconducting Quantum Processor von Gong, Ming, Chen, Ming-Cheng, Zheng, Yarui, Wang, Shiyu, Zha, Chen, Deng, Hui, Yan, Zhiguang, Rong, Hao, Wu, Yulin, Li, Shaowei, Chen, Fusheng, Zhao, Youwei, Liang, Futian, Lin, Jin, Xu, Yu, Guo, Cheng, Sun, Lihua, Castellano, Anthony D., Wang, Haohua, Peng, Chengzhi, Lu, Chao-Yang, Zhu, Xiaobo, Pan, Jian-Wei

Volltext

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study von Faivre, S., Niccoli, P., Castellano, D., Valle, J.W., Hammel, P., Raoul, J.-L., Vinik, A., Van Cutsem, E., Bang, Y.-J., Lee, S.-H., Borbath, I., Lombard-Bohas, C., Metrakos, P., Smith, D., Chen, J.-S., Ruszniewski, P., Seitz, J.-F., Patyna, S., Lu, D.R., Ishak, K.J., Raymond, E.

Volltext

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up von Balar, A.V., Castellano, D.E., Grivas, P., Vaughn, D.J., Powles, T., Vuky, J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N.J., Climent, M.A., Necchi, A., Petrylak, D.P., Plimack, E.R., Xu, J.Z., Imai, K., Moreno, B.H., Bellmunt, J., de Wit, R., O’Donnell, P.H.

Volltext

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE) von Grande, E, Capdevila, J, Castellano, D, Teulé, A, Durán, I, Fuster, J, Sevilla, I, Escudero, P, Sastre, J, García-Donas, J, Casanovas, O, Earl, J, Ortega, L, Apellaniz-Ruiz, M, Rodriguez-Antona, C, Alonso-Gordoa, T, Díez, J J, Carrato, A, García-Carbonero, R

Volltext

EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma von Rosenberg, J.E., Powles, T., Sonpavde, G.P., Loriot, Y., Duran, I., Lee, J.-L., Matsubara, N., Vulsteke, C., Castellano, D., Mamtani, R., Wu, C., Matsangou, M., Campbell, M., Petrylak, D.P.

Volltext

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative b... von Conteduca, V., Wetterskog, D., Sharabiani, M.T.A., Grande, E., Fernandez-Perez, M.P., Jayaram, A., Salvi, S., Castellano, D., Romanel, A., Lolli, C., Casadio, V., Gurioli, G., Amadori, D., Font, A., Vazquez-Estevez, S., González del Alba, A., Mellado, B., Fernandez-Calvo, O., Méndez-Vidal, M.J., Climent, M.A., Duran, I., Gallardo, E., Rodriguez, A., Santander, C., Sáez, M.I., Puente, J., Gasi Tandefelt, D., Wingate, A., Dearnaley, D., Demichelis, F., De Giorgi, U., Gonzalez-Billalabeitia, E., Attard, G.

Volltext

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETN... von Garcia-Carbonero, R., Capdevila, J., Crespo-Herrero, G., Díaz-Pérez, J.A., Martínez del Prado, M.P., Alonso Orduña, V., Sevilla-García, I., Villabona-Artero, C., Beguiristain-Gómez, A., Llanos-Muñoz, M., Marazuela, M., Alvarez-Escola, C., Castellano, D., Vilar, E., Jiménez-Fonseca, P., Teulé, A., Sastre-Valera, J., Benavent-Viñuelas, M., Monleon, A., Salazar, R.

Volltext

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG) von Aparicio, J., Maroto, P., García del Muro, X., Sánchez-Muñoz, A., Gumà, J., Margelí, M., Sáenz, A., Sagastibelza, N., Castellano, D., Arranz, J.A., Hervás, D., Bastús, R., Fernández-Aramburo, A., Sastre, J., Terrasa, J., López-Brea, M., Dorca, J., Almenar, D., Carles, J., Hernández, A., Germà, J.R.

Volltext

Overall material usage effectiveness (OME): a structured indicator to measure the effective material usage within manufacturing processes von Braglia, M., Castellano, D., Frosolini, M., Gallo, M.

Volltext

Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer von DROR MICHAELSON, M, OUDARD, Stephane, LAESTADIUS, Fredrik, ULLEN, Anders, BAHL, Amit, CASTELLANO, Daniel, GSCHWEND, Juergen, MAURINA, Tristan, CHOW MANEVAL, Edna, WANG, Shaw-Ling, LECHUGA, Maria Jose, PAOLINI, Jolanda, OU, Yen-Chuan, ISAN CHEN, SENGELØV, Lisa, SAAD, Fred, HOUEDE, Nadine, OSTLER, Peter, STENZL, Arnulf, DAUGAARD, Gedske, JONES, Robert

Volltext

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma von Gore, M E, Szczylik, C, Porta, C, Bracarda, S, Bjarnason, G A, Oudard, S, Lee, S-H, Haanen, J, Castellano, D, Vrdoljak, E, Schöffski, P, Mainwaring, P, Hawkins, R E, Crinò, L, Kim, T M, Carteni, G, Eberhardt, W E E, Zhang, K, Fly, K, Matczak, E, Lechuga, M J, Hariharan, S, Bukowski, R

Volltext

DNA sequence diversity and the efficiency of natural selection in animal mitochondrial DNA von James, J, Castellano, D, Eyre-Walker, A

Volltext

Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma von Garcia-Donas, J., Leandro-García, L.J., González del Alba, A., Morente, M., Alemany, I., Esteban, E., Arranz, J.A., Climent, M.A., Gallardo, E., Castellano, D.E., Bellmunt, J., Mellado, B., Puente, J., Moreno, F., Font, A., Hernando, S., Robledo, M., Rodríguez-Antona, C.

Volltext

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III Ch... von Tannir, N.M., Albigès, L., McDermott, D.F., Burotto, M., Choueiri, T.K., Hammers, H.J., Barthélémy, P., Plimack, E.R., Porta, C., George, S., Donskov, F., Atkins, M.B., Gurney, H., Kollmannsberger, C.K., Grimm, M.-O., Barrios, C., Tomita, Y., Castellano, D., Grünwald, V., Rini, B.I., Jiang, R., Desilva, H., Fedorov, V., Lee, C.-W., Motzer, R.J.

Volltext

Recent advances in neoadjuvant immunotherapy for urothelial bladder cancer: What to expect in the near future von Rey-Cárdenas, M., Guerrero-Ramos, F., Gómez de Liaño Lista, A., Carretero-González, A., Bote, H., Herrera-Juárez, M., Carril-Ajuria, L., Martín-Soberón, M., Sepulveda, J.M., Billalabeitia, E.G., Castellano, D., de Velasco, G.

Volltext

The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain von POCKETT, R.D., CASTELLANO, D., MCEWAN, P., OGLESBY, A., BARBER, B.L., CHUNG, K.

Volltext

Dust Environment Model of the Interstellar Comet 2I/Borisov von Cremonese, G., Fulle, M., Cambianica, P., Munaretto, G., Capria, M. T., Forgia, F. La, Lazzarin, M., Migliorini, A., Boschin, W., Milani, G., Aletti, A., Arlic, G., Bacci, P., Bacci, R., Bryssinck, E., Carosati, D., Castellano, D., Buzzi, L., Rubbo, S. Di, Facchini, M., Guido, E., Kugel, F., Ligustri, R., Maestripieri, M., Mantero, A., Nicolas, J., Ochner, P., Perrella, C., Trabatti, R., Valvasori, A.

Volltext

Translational research in neuroendocrine tumors: pitfalls and opportunities von Capdevila, J, Casanovas, O, Salazar, R, Castellano, D, Segura, A, Fuster, P, Aller, J, García-Carbonero, R, Jimenez-Fonseca, P, Grande, E, Castaño, J P

Volltext

Clinicopathological differences between familial colorectal cancer type X and sporadic cancer in an isolated area of spain von Medina-Arana, V., Rahy-Martín, A., Delgado-Plasencia, L., Martínez-Riera, A., León-Ayllón, D., Rodríguez-Castellano, D., Bravo-Gutiérrez, A., Fernández-Peralta, A., González-Aguilera, J. J.

Volltext

Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enha... von Bellmunt, J., González-Larriba, J.L., Prior, C., Maroto, P., Carles, J., Castellano, D., Mellado, B., Gallardo, E., Perez-Gracia, J.L., Aguilar, G., Villanueva, X., Albanell, J., Calvo, A.

Volltext